
Chronic exposure to stress can negatively affect gastrointestinal (GI) functions1-3 and plays an important role in the development exacerbation of GI disorders as irritable bowel syndrome (IBS).4-6 IBS is defined by recurrent abdominal pain associated with altered bowel habits,7 and it is one of the most common functional GI disorders in Western countries with a significant socioeconomic impact.8 Diverse pathological factors, including physical and psychological stressors, have been proposed to disturb gut-brain bi-directional communication.3-7,9 These factors lead to gut dysmotility and enhanced visceral pain,10-12 and contribute to the development of IBS. Brain-gut axis communication involves coordinated responses of the enteric nervous system (ENS), the autonomic nervous system, the hypothalamic-pituitary-adrenal axis, and neuro-immuno endocrine mediators.13,14 Chronic psychological stress increases HPA axis and autonomic nervous system activity which promotes modulation in monoaminergic systems signaling including the dopaminergic (DA), noradrenergic (NA), and serotonergic (5-HT) circuitries involved in the regulation of gut physiology and brain-gut axis function.1,3-6,11,14,15 Much of our knowledge about chronic stress-induced dysfunction of GI physiology and brain-gut axis comes from rodent models,9 though the specific molecular mechanisms underlying stress-induced enteric neuroplasticity remain elusive.16-18 Clinical data show neuroplastic changes (increased neuronal outgrowth as well as features of enteric glial cells activation) in the colonic mucosa of IBS patients associated with visceral hypersensitivity.19,20 Different studies support the role of neuroimmune activation in psychological stress-induced visceral hyperalgesia.18,21 In line with this, we have demonstrated that chronic psychological stress in mice results in increased visceral hypersensitivity associated with up-regulation of Toll-like receptor (TLR) 4 and microglia activation within CNS, as well as increased social anxiety-like behaviour.22,23 Therefore, this study aims to investigate whether chronic psychological stress affects intestinal functions (motility and secretion) and to examine neuroplasticity and immune-related changes that may underpin such effects.
Adult male C57BL/6J mice (n = 60; 8 weeks of age) were used as experimental mice, and adult male CD-1 mice (n = 20; 9-10 weeks of age) were used as resident aggressors, and additional C57BL/6J mice (n = 8; 8-9 weeks of age) were used to train the aggressor CD-1 mice, all animals were purchased from Envigo (Huntingdon, UK). All mice were singly housed in standard mouse cages (33X15X13 cm) with only white bedding without additional enrichment, and had ad libitum access to food and tap water under a 12-hour light/dark schedule (light on at 5 AM) with standard controlled conditions (21 ± 1℃, 55 ± 10% humidity) throughout the study. None of the procedures required a fasting period. Once weekly, home cages were cleaned and equipped with new white bedding before stool collection by the same researcher. All animal care and experimental procedures were carried out following the European Community Council Directive (86/609/EEC) and approved by the Animal Experimentation and Ethics Committee.
One day before starting the chronic unpredictable stress (CUS) protocol, mice were balanced based on body weight and randomly assigned to either the CUS or control group (n = 10 each). Afterwards, experimental mice were randomized into 3 separate cohorts (n = 20 each) for GI motility and secretomotory function, molecular markers, and behavior analysis (Fig. 1). CUS procedure was carried out as described previously.22 Briefly, mice were exposed to an unpredictable mixed model that comprised social defeat and overcrowding sessions throughout 19 days (Supplementary Methods).
At the end of the experimental paradigm and procedures, mice were sacrificed just at the beginning of the dark phase (between 4:30 PM and 6 PM) based on our previous findings for this CUS protocol,22,23 and on the circadian pattern of plasma corticosterone concentrations, which are higher during the early dark phase. Trunk blood was collected into EDTA-coated tubes. Plasma corticosterone concentration was quantified with commercially available enzyme immunoassay kits, namely Enzo ADI-901-097 (Enzo Life Sciences, Exeter, UK, LTD) according to the manufacturer’s instructions (Supplementary Methods).
The following day of the last stress session (between 9 AM and 1 PM), fat and lean body mass were determined. Measurements were carried out with conscious mice in a 3-minute trial using the Minispec mq benchtop NMR spectrometer (Bruker Instruments, Rheinstetten, Germany).24,25
The following day of the last stress session (between 9 AM and 1 PM), social avoidance behavior was assessed as described previously in the social interaction test (Supplementary Methods).22
Tissue concentration of NA, DA, 5-HT, and their metabolites were quantified in the full-thickness terminal ileum, proximal and distal colon tissue from both experimental groups by high-performance liquid chromatography (HPLC) coupled to electrochemical detection, using a modification of a previously described procedure (Supplementary Methods).26
To determine the differential transcriptional profile associated with the regulation of the ENS functions, total RNA was extracted from full thickness terminal ileum, proximal and distal colon with the Qiagen RNeasy Lipid Mini Kit (Qiagen, Valencia, CA,USA). Complementary DNA was synthesized with 1 mg total RNA with random primers. Quantitative changes in mRNA levels were estimated by quantitative real-time polymerase chain reaction (Supplementary Methods).
Western blot was performed to determine the protein levels of glial fibrillary acidic protein (GFAP), S100 calcium-binding protein B (S100B), and protein gene product 9.5 (PGP 9.5) from homogenized tissues from the proximal colon (Supplementary Methods).
Experiments reported in this study used mouse caecum due to its optimal size and different segments of the colon were processed and used for subsequent analysis. Paired mucosa submucosa preparations from each animal (n = 6) were mounted in Ussing chambers (Harvard Apparatus, Kent, UK) (Supplementary Methods).
The cytokines amount such as IL-1β, 6, 10, 12, IFN-γ, mouse keratinocyte-derived cytokine, and TNF-α on spleen cells cultured with lipopolysaccharide (LPS), phorbol 12-myristate 13-acetate (PMA), and lipoteichoic acid (LTA) (Sigma-Aldrich, Wicklow, Ireland) was quantified using custom mouse Multi-Spot 96 Well Plates (Meso Scale Discovery, Rockville, MD, USA) according to manufacturer’s recommendations (Supplementary Methods).
Data are represented in the text and figures as mean values ± SEM. Statistical analysis was performed using repeated measures two-way ANOVA for overall effects in the analysis of body weights followed by Bonferroni post hoc test. The Student’s
Chronic psychological stress significantly induced an increase in body weight in mice compared with control mice, from day 10 to the end of the CUS procedure (stress:
CUS protocol induced a reduction in evening corticosterone levels in plasma at day 19 compared to controls (Fig. 2A).
Similar to our previous data,23 the animals exposed to 19 days of CUS exhibited pronounced social avoidance behaviour as reflected by an alteration in the social interaction ratio compared with the control group (Fig. 2B).
Following 5 days of CUS, the fecal water content was increased in stressed mice compared with control mice, while no differences were observed in fecal pellet counts (Table 1). However, at the end of the procedure, water content was comparable to control mice whereas stool output was significantly reduced (Table 1), indicating that CUS protocol appears to delay GI motility. Consistently, during the dark cycle, CUS mice displayed significant delay in GI transit compared to control animals (Fig. 2C) that was not associated with decreased plasma corticosterone levels (Fig. 2D).
Table 1 . Comparison of Number of Fecal Pellets and Fecal Water Content Between Groups (n = 16-20 group) Over Chronic Unpredictable Stress Procedure
Day | Control | Stress | |||
---|---|---|---|---|---|
Fecal pellet output | Fecal water content (%) | Fecal pellet output | Fecal water content (%) | ||
5 | 2.5 ± 0.4 | 61.6 ± 1.4 | 2.6 ± 0.4 | 77.4 ± 3.7** | |
12 | 2.9 ± 0.4 | 65.8 ± 2.0 | 2.2 ± 0.4 | 68.8 ± 2.5 | |
19 | 3.1 ± 0.4 | 60.7 ± 2.1 | 1.8 ± 0.3* | 63.5 ± 2.0 |
*
Data represent mean ± SEM.
Under basal conditions, Cl--secretory short-circuit current (Isc) values were comparable in the cecum of both experimental groups (Supplementary Fig. 2A). Electrogenic Na+ absorption was present in the cecum of both groups, as evidenced by the amiloride-induced decrease of Isc without significant difference among them (Supplementary Fig. 2C-E). The addition of bethanechol and forskolin elicited a sustained increase in Isc that was similar between groups. To assess the CUS impact on the intestinal epithelial barrier integrity, transepithelial resistance of cecal explants among groups was analyzed, demonstrating no significant difference between stressed mice and controls (Supplementary Fig. 2B).
Based on our observation that chronic stress alters GI motility, we examined along different intestinal full-thickness sections the content of diverse neurotransmitters as well as the expression pattern of genes involved in their regulation. Differences in noradrenalin and dopamine (catecholamines) levels between both groups were found only in the proximal colon, where CUS mice displayed higher catecholamine content than controls (Fig. 3A). While catecholamines levels in the proximal colon were increased, we did observe reduced expression of tyrosine hydroxylase (
Given that CUS-induced GI motility and neurotransmitter dysfunction, we next examined if CUS could differentially modulate the expression of ENS markers involved in regulating intestinal plasticity and motility along the different intestinal segments. As shown in Figure 4A, there was a down-regulation of
In order to examine if disruption of the ENS and intestinal dysfunction can reflect a systemic inflammatory process through TLRs activation, we evaluated the differential cytokine production in TLR-ligand-mediated in the periphery. Spleens from both groups were stimulated with a selective TLR2 and TLR4 agonist. In agreement with our previous results,24 splenocytes of CUS mice displayed increased levels of IL-12, IL-6, TNF-α, and mouse keratinocyte-derived cytokine in response to LPS, a TLR4 agonist, compared with the control group (Supplementary Table). In contrast, similar amounts of IL-6, TNF-α, IL-10, and IL-12 were produced by splenocytes upon stimulation with lipoteichoic acid and PMA in both groups (data not shown). Then, based on the potential role of TLRs signaling in the development and maintenance of a proper ENS, we analyzed the differential expression of transcripts encoding
Table 2 . Pearson’s Correlation Analysis Between
Gene mRNA | |||||
---|---|---|---|---|---|
0.55 | 0.002a | –0.15 | 0.564 | ||
0.77 | 0.010a | 0.03 | 0.893 | ||
0.48 | 0.004a | 0.24 | 0.332 | ||
0.67 | 0.003a | 0.08 | 0.745 | ||
–0.52 | 0.024a | 0.61 | 0.008a |
Growing evidence highlights the critical role of neurotransmitters in the regulation of GI physiology and homeostasis maintenance. To support this idea, we analyzed the relationship in the proximal colon between amine content and the expression levels of all transcripts measured. Catecholamine content in the proximal colon of CUS inversely correlated with
Table 3 . Correlation Between Neurotransmitters Concentration (Noradrenaline, Dopamine, and Serotonin) and Expression Levels of Transcripts Encoding Genes Involved in the Function of ENS in the Proximal Colon of Control and Stress Mice
Gene mRNA | NA (ng/g) | DA (ng/g) | 5-HT (µg/g) | |||||
---|---|---|---|---|---|---|---|---|
–0.54 | 0.048a | –0.41 | 0.143 | –0.48 | 0.065 | |||
–0.45 | 0.092 | –0.31 | 0.253 | –0.53 | 0.034a | |||
–0.57 | 0.026a | –0.49 | 0.067 | –0.70 | 0.003a | |||
0.16 | 0.576 | 0.43 | 0.105 | 0.31 | 0.245 | |||
–0.57 | 0.028a | –0.55 | 0.033a | –0.73 | 0.001a | |||
–0.06 | 0.843 | 0.47 | 0.088 | 0.14 | 0.614 |
NA, noradrenaline; DA, dopamine; 5-HT, serotonin;
In the present study, we provide novel molecular insights into stress-induced mechanisms evoking constipation and enteric neuroplasticity. First, in our chronic stress model, a slow gut transit is observed and accompanied by a decrease in fecal output without changes in fecal water content. Second, along the intestinal segments evaluated, chronic psychosocial stress caused a marked decrease in the expression of glial-specific molecular markers,
Emerging evidence shows that mood disorders are comorbid with functional constipation and constipation-predominant IBS. Moreover, neurological disorders are often associated with GI dysmotility,27,28 explained by the structural and neurochemical similarities that share ENS with CNS. It requires a proper network of enteric neuronal and glial cells with balanced neurotransmission for GI physiological function regulation.29,30
Chronic constipation is a multifactorial disorder with a complex pathogenesis that includes abnormalities within the ENS.31,32 In terms of animal models, different approaches have been used to provide a better understanding of the pathophysiology of constipation where changes in density and/or altered morphology of the ENS, as well as altered neurotransmission, have been found.33,34 To date, less is known about the mechanism by which chronic stress impacts normal enteric neurotransmission and both motor and sensory functions. Here, chronic stress-induced imbalance in neurotransmitters levels within the proximal colon with accompanying molecular changes that might compromise the ENS function.
Interestingly, our data show again that those mice exposed to CUS exhibited social anxiety-like behavior.23 Two animal models that resemble IBS-like features exhibited increased stress-induced neurochemical and ultrastructural changes in ENS in both the small intestine17 and distal colon,18 and an association between enteric glial cells (EGCs) activity and higher colonic contractility.18 Advances in enteric neurobiology support EGCs as important players in enteric neuroplasticity, neurotransmission,35 and mucosal immune response balance.28,36,37
Another interesting feature is their contribution to the regulation of motility patterns and their outstanding plasticity, although today remains unclear under which specific conditions they switch.38 Numerous reports show EGCs loss in colon biopsy specimens from patients with altered GI motility.20,28,39 In the present study, stressed mice exhibit different expression patterns of glial-specific molecular markers between the proximal colon and distal colon compared with controls, and changes in Gfap expression in the proximal colon are inversely correlated with the NA levels. Notably, ion transport in the caecum was not affected by chronic stress-related molecular changes in the ENS of the proximal colon.
Indeed, this result could explain that mice exposed to CUS exhibited reduced stool output without changes in water content. Although not shown in this study, in the presence of impaired intestinal transit, dysbiosis is the rule, what could determine the balance between absorption and secretion, but also cecal permeability, by multiple mechanisms, being one of the most frequent the increased levels of 5-HT and tryptamine that mediates colonic secretion through serotonin 4 receptor. Despite that we cannot associate the motility readouts with neurotransmitter concentration, increased levels of DA levels in the proximal colon might be the main factor, which explains CUS-induced intestinal dysmotility. Thus, it has been previously shown the inhibitory effect of dopamine on intestinal motility through its receptor D2.40
Of interest, preclinical studies have previously reported altered intestinal transit, whereas fecal water content41 or ion transport were unchanged after pharmacological disruption of EGCs function.42
NTFs as well as EGCs are important players in supporting neurotransmission and neuroplasticity,43 indeed colonic
The cellular and molecular pathways underlying the ENS organization and activity are unclear, yet recent studies suggest the potential role of TLR-mediated signalling.46-48 It is known that different TLRs are expressed in both CNS and ENS, regulating enteric neuronal plasticity and neurotransmission.49 Indeed, the absence of TLR2 and TLR4 signaling alters GI motility may, in part, results from their role in modulating the magnitude of motor response elicited by 5-HT in the proximal colon,50 enteric neurotransmission,47,48 and glial phenotype by regulating NTFs production. Furthermore, a significant reduction in
Taken together, all these findings suggest a potential association between changes in neuroplasticity through
Indeed, our laboratory has shown different TLRs expression profiles in colonic mucosa in 2 distinct stress animal models,51 besides in this CUS paradigm we have exhibited the contribution of TLR4-dependent mechanism to stress-induced visceral hypersensitivity through activation of microglia within the CNS.23 As well, other IBS stress-based rodent model advocated for the role of TLR4 signaling coupled with increased colonic glial activation in visceral pain.52 In this line, our study shows an increased of both
On the other hand, an enhanced expression of TLR2 and TLR4 on splenic macrophages has been shown in a model of repeated social defeat.53 Therefore, our group has also shown peripheral enhanced TLR4 activity associated with a visceral hyperalgesic phenotype in DIO mice.54 Our current results indicate heightened TLR4 activity of peripheral immune cells following CUS results in increased LPS-induced release of several pro-inflammatory cytokines. Finally, it is important to note that various animal models have proved how acute or repetitive exposure to homotypic stress, mediates intestinal pathology and psychiatric disorders.55-57
However, the predictive validity of those models remains disputed because in socially organized mammals, dominant stressors in natural conditions are frequently heterotypic and complex, and best represented by social experiences.58 The combination of social defeat and overcrowding that we used in this study reflects better the stress experienced by humans on a daily basis.
In addition, our study has several limitations: we did not conduct a metagenomics analysis of the intestinal microbiome to assess the impact of CUS in gut microbiota and its metabolic activity, so we cannot rule out the influence of microbiota on gut motility, ENS disruption, and secretion/absorption process through Tlr signaling; second, in our model, only male mice have been employed, and therefore, we recognize the potential sex-bias in our conclusions on the impact of chronic stress on colonic neuroplasticity and neurotransmission. Therefore, studies comparing responses between sexes are certainly warranted; third, gut motility and secretion/absorption are certainly regulated by multiple signaling pathways not analyzed in this study. Thus, further work is necessary to clarify whether other pathways participate in the regulation of gut motility in constipation.
Unfortunately, the present design was limited in exploring the relationship between stress anxiety-like behavior and the delay in GI transit time in the same cohort, as well the lack of functional characterizations analyses focused on EGCs and neurons are required in order to provide further insight into regional functional changes in motility.
Finally, further mechanistic studies are needed to determine how these transcriptional changes contribute to stress-induced visceral hypersensitivity and motility dysfunction. While our work does not provide a specific underlying mechanism, it offers an overview of how the effects of chronic stress could vary across GI tract segments. These findings might reflect the complex nature of the chronic psychological stress impact on intestinal motility. Thus, advancing our understanding of the mechanism(s) by which the ENS responds to stress serves to elucidate the biology supporting stress-related GI disorders, and requires further evaluation as therapeutic targets to counteract the consequences of chronic stress. This study would give new insights into stress-induced constipation, and further studies in constipation-predominant IBS are needed to investigate molecular changes related to the ENS integrity function.
Note: To access the supplementary table, figures, and methods mentioned in this article, visit the online version of
We would like to thank Rachel D Moloney and Mr Patrick Fitzgerald for their technical assistance and Dr Bruno M Godinho for help with spleen stimulation studies.
This study was supported in part by Fondo Europeo de Desarrollo Regional (FEDER), Fondo de Investigación Sanitaria, and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Subdirección General de Investigación Sanitaria, Ministerio de Economía y Competitividad: CM08/00229 and Beca Estada l’estranger (Societat Catalana Digestología) 2011 and PI19/01643 (Beatriz Lobo); PI17/01902 (Javier Santos) CIBEREHD (Javier Santos); Vall d’Hebron Institut de Recerca. FONDECYT #1181699 and #11121527; MECESUP 0608 Universidad de Chile (Caroll Beltran). The work described herein was supported by APC Microbiome Ireland, funded by Science Foundation Ireland (SFI), through the Irish Government’s National Development Plan. The authors and their work were supported by SFI (Grant No. 02/CE/B124, 07/CE/B1368, and SFI/12/RC/2273).
The authors disclose the following: Javier Santos serves as a consultant for Noventure and discloses present or past recent scientific collaborations with Salvat, Norgine, Alfa-Sigma, Cosmo, Adare, Devintec Pharma, Pileje, and Danone. John F Cryan has been an invited speaker at meetings organized by Precision Biotics, Alkermes, and Janssen and has received research funding from Cremo, Nutricia, DuPont (IFF), and is a consultant for Alkermes and Nestlé. Timothy G Dinan has been an invited speaker at meetings organized by Servier, Lundbeck, Janssen, and AstraZeneca and has received research funding from Cremo, Nutricia. The remaining authors declare no competing interests. The study was carried out in APC Microbiome Institute Biosciences Building, University College Cork, Western Road, Cork, Ireland.
Beatriz Lobo conceived of the experiments; Beatriz Lobo, Mónica Tramullas, Beate-C Finger, Niall P Hyland, and John F Cryan supervised the experiments; Beatriz Lobo, Mónica Tramullas, Beate-C Finger, Kevin W Lomasney, and Caroll Beltran conducted the experiments; Beatriz Lobo wrote the initial draft of the manuscript; and Beatriz Lobo, Mónica Tramullas, Gerard Clarke, Javier Santos, John F Cryan, and Timothy G Dinan wrote subsequent drafts of the manuscript.
![]() |
![]() |